Press Releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Jun 22, 2022
DaVita Inc. (NYSE: DVA), announced today it will hold a special conference call with investors on Thursday, June 23, 2022, at 8:45 a.m. Eastern Time. This call follows this week's U.S. Supreme...
-
May 26, 2022
Companies join forces to accelerate kidney care device innovation and improve patient outcomes DUBLIN and DENVER, May 26, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT) and DaVita Inc. (NYSE: DVA)...
-
May 10, 2022
DaVita today announced that 56 of its nephrology nurses were honored with the DAISY Award® for Extraordinary Nurses during National Nurses Week. The award is part of the DAISY Foundation's™...
-
May 9, 2022
DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, will participate in a fireside chat with investors at the Bank of America Securities 2022 Healthcare...
-
May 5, 2022
DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended March 31, 2022. For the quarter, diluted earnings per share was $1.61, a decrease of (10.1)% from the prior...
-
May 3, 2022
Today, DaVita Inc. highlighted its continued commitment to corporate citizenship with the publication of its annual Community Care Environmental Social Governance (ESG) Report. "I'm humbled...
-
Apr 21, 2022
DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss first quarter results on Thursday, May 5, 2022, at 5 p.m. Eastern Time. The company plans to...
-
Apr 7, 2022
DaVita Inc. announced today that its board of directors appointed a new independent director, Jason M. Hollar, to join the board, effective May 6, 2022. Mr. Hollar brings more than 25 years of...
-
Apr 4, 2022
Results demonstrate the importance of vaccinating patients at trusted sites of care DENVER and WALTHAM, Mass., April 4, 2022 /PRNewswire/ -- A federal partnership established to help increase...
-
Feb 17, 2022Research further demonstrates COVID-19 vaccination as an important clinical strategy to help protect vulnerable patients from infection
Dialysis patients who received an adenovirus vector-based COVID-19 vaccine (Johnson & Johnson) were found to have similar rates of breakthrough infection, hospitalization and mortality as dialysis...